Aster DM Healthcare Publishes Postal Ballot Notice for Executive Director Appointment

3 min read     Updated on 14 Mar 2026, 02:48 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Aster DM Healthcare has published its postal ballot notice in newspapers as required under Regulation 30, seeking shareholder approval for founder Dr. Azad Moopen's appointment as Executive Director and authorization for financial assistance up to ₹1,500 crores. The e-voting process runs from March 14 to April 12, 2026, with results expected by April 14, 2026.

powered bylight_fuzz_icon
34697183

*this image is generated using AI for illustrative purposes only.

Aster DM Healthcare Limited has issued a postal ballot notice dated March 13, 2026, seeking shareholder approval for critical corporate matters following the board's earlier decision to appoint founder Dr. Azad Moopen as Executive Director. The company has now published this notice in newspapers as required under regulatory compliance.

Newspaper Publication and Regulatory Compliance

On March 14, 2026, the company published its postal ballot notice in Financial Express (English Language) and Andhra Jyothi (Telugu Language) newspapers, fulfilling the regulatory requirements under Regulation 30. This publication ensures wider dissemination of information to shareholders and the general public regarding the upcoming postal ballot.

Publication Details: Information
Publication Date: March 14, 2026
English Newspaper: Financial Express
Regional Newspaper: Andhra Jyothi (Telugu)
Regulatory Compliance: Regulation 30
Company Website: www.asterdmhealthcare.in

Postal Ballot Process and Timeline

The company has initiated the postal ballot process in compliance with SEBI regulations, with voting restricted to electronic mode only. The postal ballot notice has been sent electronically to all eligible shareholders whose email addresses are registered with the company or depositories.

Parameter: Details
Cut-off Date: Friday, March 6, 2026
E-voting Start: Saturday, March 14, 2026 at 9:00 AM (IST)
E-voting End: Sunday, April 12, 2026 at 5:00 PM (IST)
Results Declaration: On or before Tuesday, April 14, 2026
Scrutinizer: Mr. Rajiv Balakrishnan, Beyond Compliance Corporate Services

Special Business Items for Approval

The postal ballot seeks shareholder approval for two critical special resolutions that will shape the company's future operations and governance structure.

Executive Director Appointment

The primary resolution concerns the appointment of Dr. Mandayapurath Azad Moopen (DIN: 00159403) as Executive Director, transitioning from his current role as Managing Director. This strategic redesignation aligns with the proposed amalgamation of Quality Care India Limited with the company.

Appointment Details: Specifications
Term Period: April 15, 2026 to May 28, 2028
Remuneration: Up to ₹10.00 crores per annum
Current Age: 72 years
Board Tenure: Since January 18, 2008
Shareholding: 1,470,676 equity shares directly
Beneficial Ownership: 18,68,53,810 shares (36.06% through Union Investment)

Financial Assistance Authorization

The second resolution seeks approval for granting loans, guarantees, or securities under Section 185 of the Companies Act, 2013, to group entities where directors may have interests.

Financial Parameters: Details
Maximum Limit: ₹1,500 crores
Validity Period: Three years from approval date
Permitted Usage: Principal business activities only
Interest Terms: Commercial rates at market conditions

Leadership Profile and Market Performance

Dr. Azad Moopen, a Gold Medallist in MBBS from Calicut Government Medical College, has transformed the organization from a single-doctor clinic in Dubai (1987) into a leading global healthcare network spanning seven countries with over 500 healthcare facilities.

Under his leadership, the company has demonstrated consistent financial growth:

Financial Year: Operating Revenue (₹ crores) Operating EBITDA (₹ crores) PAT (₹ crores) Market Cap (₹ crores)
FY25: 4,138.00 806.00 307.00 24,067.00
FY24: 3,699.00 620.00 188.00 20,357.00
FY23: 2,983.00 477.00 147.00 11,970.00

Regulatory Compliance and Governance

The appointments have been structured in full compliance with applicable regulations, including SEBI Listing Obligations and Disclosure Requirements. The Nomination and Remuneration Committee and Audit Committee have provided their recommendations and approvals respectively.

The company has confirmed that Dr. Azad Moopen is not debarred from holding directorial positions and satisfies all conditions prescribed under Schedule V of the Companies Act. His appointment remains subject to Central Government approval as required for persons above 70 years of age.

Shareholders can access the complete postal ballot notice on the company's website and cast their votes through the NSDL e-voting platform during the specified voting period.

Historical Stock Returns for Aster DM Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
+0.30%+6.87%+2.35%+7.18%+47.79%+389.77%

Aster DM Healthcare Reports INR 17.68 Crore Loss Due to Kerala Nurse Strike

2 min read     Updated on 14 Mar 2026, 02:41 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Aster DM Healthcare Limited reported a revenue loss of INR 17,68,74,860 from March 8-13, 2026, due to a statewide nurse strike affecting seven Kerala hospitals. The strike, demanding wage structure revisions, caused reduced occupancy and skeletal staffing. Kerala High Court ordered strike deferment until March 19, 2026, providing relief as nurses began returning. The company activated contingency measures and mobilized staff from neighboring states to maintain critical care services.

powered bylight_fuzz_icon
35025073

*this image is generated using AI for illustrative purposes only.

Aster DM Healthcare Limited has reported significant operational disruption and financial impact due to a statewide nurse strike affecting its seven hospitals in Kerala. The company disclosed a revenue loss of INR 17,68,74,860 during the period from March 8 to March 13, 2026, in a regulatory filing under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements.

Strike Details and Impact

The nursing staff strike, led by the United Nurses Association, commenced on March 9, 2026, with demands for revision in wage structures. The strike has resulted in temporary disruption of operations across the company's Kerala facilities, including reduced occupancy levels and skeletal nursing staffing in most units.

Impact Parameter: Details
Revenue Loss (March 8-13): INR 17,68,74,860
Strike Duration: March 9-13, 2026
Affected Facilities: 7 hospitals in Kerala
Primary Cause: Wage structure revision demands

Affected Hospital Facilities

The strike has impacted the following hospitals operated by the company in Kerala:

  • Aster Medcity Hospital
  • Aster MIMS Calicut Hospital, Calicut
  • Aster MIMS Kannur Hospital, Kannur
  • Aster MIMS Kottakkal Hospital, Kottakkal
  • Aster Mother Hospital, Areekode
  • Aster PMF Hospital, Kollam

Court Intervention and Relief

The Kerala Private Hospital Association approached the High Court of Kerala at Ernakulam with a writ petition regarding the strike. On March 13, 2026, the Hon'ble High Court issued an order directing the Nurses Association to defer the strike and ensure that members do not abstain from work or engage in any form of strike until March 19, 2026.

Legal Development: Status
Court Order Date: March 13, 2026
Strike Deferment Until: March 19, 2026
Mediation Directive: Hospitals and nurses referred to mediation centre
Immediate Impact: Certain nurses rejoined and resumed duties

Company's Response Measures

Aster DM Healthcare has implemented several contingency measures to maintain patient care continuity:

  • Activated internal contingency protocols to ensure critical services
  • Mobilized nursing staff from other units in neighboring states like Karnataka
  • Maintained critical care operations across affected facilities
  • Engaged with industry bodies and hospital associations for resolution

Financial Projections

The company expects operations to resume normal course following the court order, with nurses returning to work. Assuming majority nurses resume operations and matters resolve by March 19, 2026, as instructed by the High Court, the company does not anticipate further losses exceeding INR 5,32,88,649 on account of the nurse strikes. The company has committed to keeping stakeholders informed of any changes in this assessment based on evolving circumstances.

The healthcare provider will continue monitoring developments closely and provide material updates to stock exchanges as required under regulatory obligations.

Historical Stock Returns for Aster DM Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
+0.30%+6.87%+2.35%+7.18%+47.79%+389.77%

More News on Aster DM Healthcare

1 Year Returns:+47.79%